School of Medicine
Showing 1-10 of 212 Results
-
Myriam Amsallem
Postdoctoral Research Fellow, Cardiovascular Medicine
BioDr. Myriam Amsallem, a cardiologist specialized in cardiac imaging, completed her training in Paris VII University, France. She has an interest in heart failure, cardioimmunology and early detection of pulmonary hypertension and right heart failure using imaging and circulating biomarkers. She is currently working on studies at Stanford University with Marie Lannelongue Hospital (French reference center for Pulmonary Hypertension, France) on studies on right heart remodeling with the goal of understanding the influence of inflammation and finding early biomarkers of remodeling. She also has a special interest in educational projects to improve the quality of imaging methodology.
-
Tessa Andermann
Postdoctoral Research Fellow, Infectious Diseases
BioI have a background in the execution of molecular biology research as a former laboratory technician for 5 years during and following my undergraduate degree in molecular, cellular, and developmental biology. I also have a background in epidemiology and statistics through my MPH at UC Berkeley during which time I mastered the application of meta-analysis and systematic review techniques to infectious diseases topics, in particular in my masters thesis on HIV directly observed therapy. In addition, my years at Stanford as an internal medicine resident, infectious diseases fellow, and immunocompromised infectious diseases fellow have further developed my desire to address important translational questions that will improve the clinical outcomes of the patients that I care for on the stem cell transplant service. I hope to find therapies that might safely and effectively supplement and even take the place of antibiotics for prophylaxis and treatment of GVHD and infectious complications.
-
Lucia Aronica
Postdoctoral Research Fellow, SCRDP/ Heart Disease Prevention
Academic Staff - Hourly - CSL, Continuing Studies and Summer SessionBioOver the past ten years my research has focused on the field of epigenetics, which investigates how environmental factors can affect gene activity thereby impacting our health and predisposition to diseases. Unlike genetic factors, epigenetic modifications are flexible and can store cell memories of life exposures such as diet, stress or environmental toxins. As such, they hold great potential in personalized health as biomarkers for exposure-driven chronic diseases such as obesity, diabetes, cardiovascular disease, and cancer.
I am currently leading the epigenetic analysis of the largest study ever undertaken in personalized nutrition on low carb vs. low fat diets – the DIETFITS study by Prof Christopher Gardner. My primary goal is to understand how weight-loss affects gene activity through epigenetic modifications, and whether we can use these modifications to predict diet response for personalized weight-loss strategies.
I also teach Nutritional Genomics at Stanford Continuing Studies, Stanford Sport Medicine and at the Stanford Center for Professional Development. An award-winning science communicator, I use creative forms of communication such as digital drawings to explain complex topics from the world of epigenetics and science. Finally, I serve as an advisor for personal genomics companies, self-tracking technology businesses, and companies interested in investing in precision health research. -
Matthew Baker
Clinical Instructor, Medicine - Immunology & Rheumatology
Postdoctoral Research Fellow, Immunology and Rheumatology
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2017BioDr. Baker is a Clinical Instructor in Rheumatology at Stanford University with a focus on patient care, bench research, and clinical trials. He studied at Harvard Medical School and trained in Internal Medicine at the Massachusetts General Hospital. He subsequently came to Stanford for his fellowship in Rheumatology and before becoming Clinical Instructor spent a year as a Postdoctoral Fellow in the laboratory of Dr. William Robinson. He continues to work with Dr. Robinson conducting basic research related to characterizing novel autoantibodies in ANCA-vasculitis. He is also working with Dr. Mark Genovese on several clinical trials with a focus on systemic lupus erythematosus, sarcoidosis, Sjogren's syndrome, and IgG4-related disease.
